Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders

Am J Psychiatry. 1983 Jun;140(6):757-60. doi: 10.1176/ajp.140.6.757.

Abstract

The authors review theoretical and clinical data supporting the hypothesis that L-tryptophan may potentiate the effects of lithium carbonate and report on a double-blind clinical comparison of lithium plus L-tryptophan and lithium plus placebo in 9 bipolar and 7 schizoaffective patients. Overall the combination of lithium and L-tryptophan resulted in significantly greater improvement. However, the results may have been confounded by the greater, although nonsignificant, doses of neuroleptics administered to the group receiving L-tryptophan. The authors discuss the interactions of lithium and L-trypotophan with the serotonin system.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / psychology
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lithium / therapeutic use*
  • Lithium Carbonate
  • Male
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / psychology
  • Tryptophan / therapeutic use*

Substances

  • Lithium Carbonate
  • Tryptophan
  • Lithium